Indeed, it would be interesting to add a genetic screening to the clinical guidelines for patients diagnosed with childhood cancer targeting the RARG- rs2229774 risk variant, the SLC28A3-rs7853758 protective variant or the harmful union of the P2RX7-rs208294 and P2RX7-rs3751143 variants. This evidence concerns the gene RARG and childhood malignant neoplasm.